The conclusion about clinical trial of a treatment-and-prophylactic substance REKITSEN-RD
версия для печати
Head Department of public health of Moscow Territorial Executive Committee The Moscow Regional Psychiatric Hospital №5
(Regulator of intestinal cenoses phytogenic yeasty), produced in Closed Corporation "Yagodnoye", Kirov City (registration certificate #O01110. P.643.08.99 Russian Federation Ministry of Health)
Clinical efficiency of REKITSEN-RD was tested within 11 months (since January, 1999 up to the present time) on the basis of psychosomatic department of the Moscow Regional Psychiatric Hospital #5 and Sergievo-Posadsky addictologic dispensary.
Taking into account basic enterosorptive (detoxicant) properties of REKITSEN-RD, it was prescribed to the following groups of patients:
- with acute alcoholic psychosis uncomplicated (135 patients);
- with moderately expressed abstinent syndrome (523 patients).
Depending on a degree of abstinent syndrome the patients were prescribed from 1 up to 3-4 tablespoonful REKITSEN-RD 3-4 times per day.
The following criteria of effectiveness were used:
- dynamics of clinical manifestations alongside with laboratory data (routine blood analysis, tests of rheologic blood properties and of its enzymatic activity);
- rate of pathological manifestations disappearance.
Treatment with REKITSEN-RD both as monotherapy or in addition to the main medical complex reliably accelerated regress of manifestations of the astheno-vegetative complex, decrease of a tachycardia, normalization of skin colouring, improvement of health state, disappearance dyspeptic manifestations (nausea, unpleasant smack in a mouth, pyrosis, gravity in a stomach, meteorism, stools disturbances).
The most important characteristic of REKITSEN-RD efficiency is much smaller termination periods of an acute alcoholic psychosis and subsequent abstinent syndrome. In numerical expression it is 1-2 days in comparison with 3-4 days in control at alcoholic psychosises and 4-5 days in comparison with 6-7 days in control at abstinent disorders.
Despite of an aggravated somatic status of the patients, treatment with REKITSEN-RD causes much faster normalization hemodynamic and enzymatic parameters with less complications observed.
Thus, REKITSEN-RD is a useful and rather effective auxiliary means for treatment of an alcoholic pathology with antitoxic, immunomodulating, hypoglycemic, hypolipiemizing properties, that implicitly facilitate treatment of the patients.
The wide informational and educational work is necessary among the physicians about unique properties of REKITSEN-RD for treatment of the patients with the above-stated pathology.
The head physician G.S. Kokayev
The major doctor V.V. Zaitsev